

Q1 2025 Investor Audibles: 1Main Capital, Alluvial Capital, NZS Capital
24 snips May 2, 2025
Get ready to dive into a thrilling analysis of current market trends and investment strategies. The journey begins with insights on navigating volatility, emphasizing defensive strategies that have yielded impressive returns, particularly in biotech. The discussion shifts to the financial maneuvers of various funds as they tackle global economic uncertainties and adapt to emerging opportunities. With expert perspectives and a focus on proactive management, this conversation is a treasure trove for savvy investors!
AI Snips
Chapters
Transcript
Episode notes
Asset Prices Drive Exposure Changes
- Asset prices shift aggregate exposures, not trading flows. - Price movements reflect weighted intentions of asset owners, not just selling volumes.
Biotech Investing Focus
- Investing in biotech focuses on cash assets and shareholder incentives, not deep science. - Cash-rich biotech firms with engaged shareholders reduce risk despite clinical trial disappointments.
Trade War Economic Impact
- Trade wars cause harmful economic confusion without immediate reshoring benefits. - Businesses pause discretionary spending amid policy uncertainty, delaying reshoring or security improvements.